- Degree of satisfaction of patients continuing overactive bladder treatment with mirabegron2017 | First Faculty of Medicine, Central Library of Charles University
- Cure effect and persistence of treatment with Mirabegron in patients with symptoms of overactive bladder: a multicentre clinical study2017 | First Faculty of Medicine
- Persistence in the treatment of overactive bladder (OAB) with Mirabegron in a multicentre clinical study2015 | First Faculty of Medicine
- How durable is the effect of mirabegron in successfully-treated overactive bladder patients? Analysis of a multicentre study2018 | First Faculty of Medicine, Central Library of Charles University
- Mirabegron v léčbě inkontinece močiPublication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no.178-CL-101Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 178-EC-001Publication without faculty affiliation
- Mirabegron - klinické zkušenosti2014 | First Faculty of Medicine
- Dlouhodobé výsledky léčby hyperaktivního močového měchýře mirabegronem v různých věkových skupinách - výsledky studie Miracle IIPublication without faculty affiliation
- Persistence in the treatment of overactive bladder syndrome (OAB) with mirabegron in a multicenter clinical study2017 | First Faculty of Medicine, Central Library of Charles University
- Impact of body mass index on treatment efficacy of mirabegron for overactive bladder in females2016 | First Faculty of Medicine, Central Library of Charles University
- Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-Prospective, randomized, double-blind, placebo-controlled study2018 | Central Library of Charles University
- History and current trends in the treatment of idiopathic overactive bladder2021 | Faculty of Medicine in Hradec Králové
- Mirabegron improves quality-of-life, treatment satisfaction, and persistence in patients with overactive bladder: a multi-center, non-interventional, real-world, 12-month study2018 | Third Faculty of Medicine
- Perzistence na léčbě mirabegronem u pacientů a pacientek s hyperaktivním močovým měchýřemPublication without faculty affiliation
- Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a beta(3)-Adrenoceptor Agonist, in Overactive Bladder2013 | Faculty of Medicine in Pilsen
- Vliv body mass index na efektivitu léčby hyperaktivního měchýře mirabegronem u ženPublication without faculty affiliation
- Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity2021 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Astellas pro vás: Perzistence na léčbě hyperaktivního močového měchýře (OAB) Mirabegronem v multicentrické klinické studii2015 | First Faculty of Medicine
- Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY)2017 | First Faculty of Medicine
- Impact of Body Mass Index on Treatment Efficacy of Mirabegron for Overactive Bladder in FemalePublication without faculty affiliation
- β3-adrenergic agonists and "browning" of the white adipose tissue: Influence on energy balance and obesity associated metabolic risks2019 | Third Faculty of Medicine
- Persistence in the treatment of OAB with mirabegron in a multicentre clinical studyPublication without faculty affiliation
- Is it possible to cure the symptoms of the overactive bladder in women?2018 | First Faculty of Medicine, Central Library of Charles University
- Perzistence na léčbě OAB a studie MIRACL2015 | First Faculty of Medicine
